Fosaprepitant Injection, Powder, Lyophilized, For Solution
Product Images NDC 63323-972

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Fosaprepitant (NDC 63323-972). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fos04 0004 01

Fos04 0004 01
Chemical structure of Fosaprepitant, a pharmaceutical compound shown in a detailed two-dimensional molecular diagram. The structure includes multiple rings, functional groups, and side chains consistent with the lyophilized injection form of Fosaprepitant.*
FDA Label Image

Fos04 0004 02

Fos04 0004 02
Label for Fosaprepitant injection, a sterile lyophilized powder for intravenous use, showing a strength of 150 mg per vial. The label includes storage instructions to refrigerate at 2°C to 8°C and discard unused portion. The labeler is Fresenius Kabi USA, LLC, with product NDC 63323-972.*
FDA Label Image

Fos04 0004 03

Fos04 0004 03
Fosaprepitant for Injection 150 mg per vial lyophilized powder for solution, labeled for intravenous use. The label indicates reconstitution with 5 mL of 0.9% Sodium Chloride. Contains inactive ingredients such as edetate disodium and polysorbate 80. Manufactured by Fresenius Kabi USA, LLC, with storage instructions and usage cautions noted on the vial label.*
FDA Label Image

Fos04 0004 04

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.